Soluble guanylate cyclase stimulator IW-1701

{
  "id": "MLC-T-ONC-016818",
  "term": "Soluble guanylate cyclase stimulator IW-1701",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable stimulator of soluble guanylate cyclase (sGC), with potential anti-inflammatory and vasodilating activities. Upon oral administration, sGC stimulator IW-1701 targets, allosterically binds to and enhances the nitric oxide (NO)-dependent catalytic activity of sGC. This enhances NO-sGC signaling and increases the formation of the intracellular second messenger cyclic guanosine monophosphate (cGMP), which is derived from guanosine triphosphate (GTP). This enhances NO/cGMP-mediated muscle relaxation, suppresses leukocyte-endothelial interactions and promotes vascular anti-inflammatory effects. The NO/sGC/cGMP signaling pathway plays an important role in vasodilation, blood flow and inflammatory processes. sGC, a heme-containing cytoplasmic signaling enzyme, catalyzes the formation of cGMP from GTP in response to NO binding to heme.",
  "synonyms": [
    "stimulator of soluble guanylate cyclase IW-1701",
    "sGC stimulator IW-1701"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/soluble-guanylate-cyclase-stimulator-iw-1701/"
}